Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2012
06/14/2012US20120145320 Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
06/14/2012DE19964594B4 Dialysis concentrate held in vessels as sludge for powder or granule components and solution of dissolved acid components for preparation of batches
06/14/2012CA2821109A1 Smart polymeric nanoparticles which overcome multidrug resistance to cancer chemotherapeutics and treatment-related systemic toxicity
06/14/2012CA2820835A1 New form of administration of enkephalinase inhibitor
06/14/2012CA2820751A1 Barley protein microcapsules
06/14/2012CA2820721A1 Methods for forming miniemulsions and use thereof for delivering bioactive agents
06/14/2012CA2820431A1 Dosage form
06/14/2012CA2820394A1 Pharmaceutical composition comprising trans-cinnamaldehyde and its use in the treatment of infections
06/14/2012CA2820297A1 Implantable devices coated with insulin-mimetic agent composites and methods thereof
06/14/2012CA2820245A1 Dosage and administration for preventing cardiotoxicity in treatment with erbb2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents
06/14/2012CA2820019A1 Stable effervescent bisphosphonate formulations with rapid solubilization characteristics
06/14/2012CA2819548A1 Highly stable compositions of orally active nucleotide analogues or orally active nucleotide analogue prodrugs
06/14/2012CA2818018A1 Liposomal formulation of dalcetrapib
06/14/2012CA2817941A1 A stable ready-to-use cetrorelix injection
06/13/2012EP2463378A1 Alpha isomaltosylglucosaccharide synthase, process for producing the same and use thereof
06/13/2012EP2463327A2 Method for producing granulates containing at least one water-soluble component
06/13/2012EP2462978A1 Applicator device of pinholder type microneedle
06/13/2012EP2462940A1 Stabilized bacteriophage formulations
06/13/2012EP2462933A1 Controlled release oral formulations of ion channel modulating compounds and related methods for preventing arrhythmia
06/13/2012EP2462929A1 Sheet-form preparation and method for producing the same
06/13/2012EP2462928A1 Sheet-form preparation and method for producing the same
06/13/2012EP2462927A1 Transdermal therapeutic system comprising fentanyl
06/13/2012EP2462926A1 Bi-layer oral adhering tablet with acacia gum adhesive
06/13/2012EP2462925A1 Pramipexole Dihydrochloride Granulate
06/13/2012EP2462924A2 Improvements in or relating to amphoteric liposomes.
06/13/2012EP2462923A2 Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions
06/13/2012EP2462922A1 New form of administration of enkephalinase inhibitor
06/13/2012EP2462921A1 Liquid pharmaceutical compositions for the treatment of a posterior eye disease
06/13/2012EP2462896A1 Method for the preparation of controlled release formulations
06/13/2012EP2462246A1 Rapid establishment and/or termination of substantial steady-state drug delivery
06/13/2012EP2462199A1 Composite pigment and method for preparation thereof
06/13/2012EP2461840A1 Ion substituted calcium phosphate particles
06/13/2012EP2461803A2 Fast-acting naproxen composition with reduced gastrointestinal effects
06/13/2012EP2461802A1 Controlled-release granular compositions containing mesalazine and process for the manufacture thereof
06/13/2012EP2461801A2 Controlled release pharmaceutical compositions of milnacipran
06/13/2012EP2461800A2 Controlled release formulations of lipocalin muteins
06/13/2012EP2461798A2 Topical pharmaceutical preparations having both a nanoparticle solution and a nanoparticle suspension and methods for the treatment of acute and chronic pain therewith
06/13/2012EP2461797A1 Process for preparation of over-the-counter gelatin or pectin-based drug delivery
06/13/2012EP2461796A2 Sublingual and buccal film compositions
06/13/2012EP2461795A2 Sublingual and buccal film compositions
06/13/2012EP2271321B1 Pharmaceutical composition 271
06/13/2012EP2243490B1 Insulin nasal powder inhalation
06/13/2012EP2124972B1 Use of a composition made of mineral nutrients and optionally acetogenic and/or butyrogenic bacteria in order to avoid or reduce the formation of gas in the large intestine of a mammal and the resulting abdominal problems
06/13/2012EP1986650B1 Tamper resistant dosage forms
06/13/2012EP1967171B1 Production method of an adhesive patch
06/13/2012EP1947110B1 Intranasal vaccine for use against disease caused by enterotoxigenic escherichia coli
06/13/2012EP1937253B1 Combined preparation of o-acetylsalicylic acid salts
06/13/2012EP1888107B1 Novel vaccine formulations
06/13/2012EP1848794B1 Compositions comprising dehydrated micro-organisms, method for preparing same, and uses thereof
06/13/2012EP1842558B1 Composition for inhibiting expression of target gene
06/13/2012EP1758561B1 Protective microcontainers
06/13/2012EP1740189B1 Lung surfactant supplements
06/13/2012EP1734927B1 Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides
06/13/2012EP1701775B2 A method and process for controlling the temperature, pressure and density profiles in dense fluid processes and associated apparatus
06/13/2012EP1675573B2 Controlled release sterile injectable aripiprazole formulation and method
06/13/2012EP1663183B9 Solid pharmaceutical dosage form comprising ritonavir
06/13/2012EP1585542B1 Immunogenic compositions containing phospholipid
06/13/2012EP1552835B1 Transdermal patch for external use comprising fentanyl
06/13/2012EP1480666B1 Immunizing composition and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein
06/13/2012EP1104296B1 Bioimplant formulation
06/13/2012CN1849112B Therapeutic liposomes
06/13/2012CN1743337B Taxol derivative and its pharmaceutical composition
06/13/2012CN1352558B Immediate release medicinal compositions for oral use
06/13/2012CN102497886A Fas (apo-1, cd95) targeted platforms for intracellular drug delivery
06/13/2012CN102497882A Stabilised composition comprising at least one adrenergic compound
06/13/2012CN102497879A Single-time vaccines
06/13/2012CN102497877A Modified erythropoietin to which water-soluble long-chain molecule is added
06/13/2012CN102497867A Pharmaceutical compositions comprising bisphosphonate derivatives and high-dose cholecalciferol
06/13/2012CN102497865A Intraocular sustained release drug delivery systems and methods for treating ocular conditions
06/13/2012CN102497859A Pharmaceutical composition and administrations thereof
06/13/2012CN102497858A Nanoparticulate telmisartan compositions and process for the preparation thereof
06/13/2012CN102497857A Nanostructured sildenafil base, its pharmaceutically acceptable salts and co-crystals, compositions of them, process for the preparation thereof and pharmaceutical compositions containing them
06/13/2012CN102497856A Ketorolac tromethamine compositions for treating or preventing ocular pain
06/13/2012CN102497855A Multi-layered gradient vaginal ring
06/13/2012CN102497854A Pharmaceutical ophthalmological liquid compositions containing propionic acid derivatives as a preservative
06/13/2012CN102497853A Dry powder formulations and methods for treating pulmonary diseases
06/13/2012CN102497852A N-hydroxylated amidine-, guanidine- and/or aminohydrazone-type prodrugs for application on the skin
06/13/2012CN102497851A Injectable composition combining a filling agent and a fibroblast growth medium
06/13/2012CN102497777A Use of cycloaliphatic diols as biocides
06/13/2012CN102491981A Amphiphilic anti-cancer drug compound modified by water-soluble vitamin E derivative, preparation, preparation method and application for compound
06/13/2012CN102489230A Preparation method of biodegradable polymer microcapsules
06/13/2012CN102488901A Cataplasm substrate with high-drug-load characteristic, and preparation method thereof
06/13/2012CN102488888A Medicinal composition containing echinocandin antifungal agent and preparation method and application thereof
06/13/2012CN102488887A Echinocandin antifungal agent caspofungin containing medicinal composition, a preparation method and application thereof
06/13/2012CN102488886A Caspofungin preparation with low impuritycontent and preparation method and application thereof
06/13/2012CN102488878A External traditional Chinese medicine composition for treating leucoderma
06/13/2012CN102488874A Method for preparing bupleurum and cassia twig freeze-dried oral preparation
06/13/2012CN102488871A Normal temperature preparation method of ultra-micro insecticide powder and special bidirectional airflow sieving machine therefor
06/13/2012CN102488866A Anti-tumor Chinese medicinal composition Qinggong Xiaoliu Wan
06/13/2012CN102488863A Chinese herbal medicine compound with anticancer effect, preparation method and detection method thereof
06/13/2012CN102488845A Chinese medicinal composition Naohuandan
06/13/2012CN102488841A Capsule or tablet for assisting memory improvement and preparation method thereof
06/13/2012CN102488840A Blood sugar reducing preparation and preparation method thereof
06/13/2012CN102488837A Sugar-free granule for treating chronic fatigue syndrome and preparation method and detecting method thereof
06/13/2012CN102488827A Preparation method for Yuye decoction lyophilized orally administrated preparation
06/13/2012CN102488826A Method for preparing freeze-dried oral preparation of spina date seed decoction
06/13/2012CN102488814A Chinese medicinal composition for treating bovine mastitis
06/13/2012CN102488810A Applications of huoxiangzhengqi soft capsule serving as medicinal preparations for treating cardiovascular and cerebrovascular diseases
06/13/2012CN102488808A Traditional Chinese medicine capsule for treating ischemic cerebrovascular disease
06/13/2012CN102488803A Preparation method for superfine bupleurum powder under normal temperature and special bidirectional airflow sieving machine